Members of the TB expert community (including civil society, affected community, doctors, nurses, researchers, policymakers, etc.) are invited to take part in the second round of a Delphi survey, led by the London School of Hygiene & Tropical Medicine, exploring the opportunities and value of offering non-TB services for people with TB and their household contacts.

Results from a community-based trial of a new package for diagnosing TB emphasise the importance of moving towards an active case finding approach for the disease.

Vulnerable populations in 45 high-burden countries worldwide must be prioritised in efforts to reduce the impact of the COVID-19 pandemic on tuberculosis (TB) care, according to new research published in BMC Medicine.

The London School of Hygiene & Tropical Medicine will host a webinar on 12 October 2022 that will explore how host and bacteria differences may affect the response to TB treatment, and will present a novel patented technology to improve the study of the impact of Mycobacterium tuberculosis lineages differences on TB treatment response.

New modelling study suggests that testing household contacts and preventive treatment could avert almost 4,000 deaths in children under 15 globally every year.

The tuberculosis (TB) vaccine Bacillus Calmette-Guérin (BCG) could protect newborns against a variety of common infections, such as upper respiratory tract infections, chest infections and diarrhoea, according to a new study in Lancet Infectious Diseases.

Study estimates at least 110,000 additional deaths from TB in China, India and South Africa unless health services maintained and strengthened.

The world’s only licensed tuberculosis (TB) vaccine could offer protection against the disease for nearly twice as long as previously thought, according to new research published in the International Journal of Epidemiology.

Finding out what drugs can be used to treat a patient with tuberculosis (TB) can be sped up by days or weeks, thanks to a new free online tool.

Locally-sourced antibiotics can be as effective as ‘internationally quality-assured’ (IQA) antibiotics for treating multidrug-resistant tuberculosis (MDR-TB) in Pakistan, and may help avoid delays in starting treatment while programmes wait for drugs to arrive from overseas, according to new research published in PLOS ONE.